Hypnotics and Sedatives - Administration & dosage
Research News and Information

Monday, November 23, 2009

Low-dose oral midazolam reduces fear and distress during needle procedures in children with cancer.

13 Dec 2009 BACKGROUND: Children with cancer often mention needle procedures as the most frightening, distressing, and sometimes painful aspect of the disease and treatment. The aim was to investigate whether children experience less fear, distress, and/or pain ... Read more...

Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat.

30 Oct 2009 BACKGROUND: The current study was designed to test the hypothesis that dexmedetomidine added to ropivacaine would increase the duration of antinociception to a thermal stimulus in a dose-dependent fashion in a rat model of sciatic nerve blockade. ... Read more...

When drugs disappear from the patient: elimination of intravenous medication by hemodiafiltration.

30 Oct 2009 Twenty-three hours after heart transplantation, life-threatening acute right heart failure was diagnosed in a patient requiring continuous venovenous hemodiafiltration (CVVHDF). Increasing doses of catecholamines, sedatives, and muscle relaxants ... Read more...

Latest indexed articles for 'Hypnotics and Sedatives - Administration & dosage'

These are the very latest articles for this heading:

• Low-dose oral midazolam reduces fear and distress during needle procedures in children with cancer. 13 Dec 2009
• "Above all, do no harm": hippocrates. 30 Oct 2009
• Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. 30 Oct 2009
• When drugs disappear from the patient: elimination of intravenous medication by hemodiafiltration. 30 Oct 2009
• Comparison between dexmedetomidine and remifentanil for intraoperative controlled hypotension. 30 Oct 2009
• Pain management and sedation for children in the emergency department. 28 Oct 2009
• [Delirium in the critically ill] 17 Oct 2009
• Propofol infusion syndrome with arrhythmia, myocardial fat accumulation and cardiac failure. 13 Oct 2009
• [Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices] 3 Oct 2009
• Last-resort options for palliative sedation. 13 Sep 2009
• [Nurse administered propofol sedation in connection with endoscopy] 12 Sep 2009
• Short half-life hypnotics preserve physical fitness and altitude tolerance during military mountainous training. 30 Aug 2009
• Treatment of insomnia in post--traumatic stress disorder. 30 Aug 2009
• Update on dexmedetomidine for adult ICU sedation. 30 Aug 2009
• The use of fospropofol during bronchoscopy. 30 Aug 2009
• A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. 30 Aug 2009
• [Nurse administered propofol sedation in connection with endoscopy] 15 Aug 2009
• [Anesthetic management in a case of myotonic distrophy with dexmedetomidine] 30 Jul 2009
• Dexmedetomidine use in general anaesthesia. 30 Jul 2009
• Intracarotid amobarbital procedure and etomidate speech and memory test. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Hypnotics and Sedatives'

Definition: Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Registry Number: 0

Descriptor UI: D006993

Alternative terms: Hypnotics and Sedatives; Sedatives and Hypnotics; Sedatives; Hypnotics;

Related Mesh Headings: Histamine H1 Antagonists; Tranquilizing Agents;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.277.350; D27.505.696.410; D27.505.954.427.210.350; D27.505.954.427.325;

Technical Notes: CNS depressants; GEN: prefer specifics; DF: HYPNOTICS